Immune Modulation by Abemaciclib in Head and Neck Squamous Cell Carcinoma (HNSCC). (AIM Trial)
Clinical trial NCT04169074 · TERMINATED
Trial details
- NCT number
- NCT04169074
- Sponsor
- University of Arizona
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-07
- Primary completion
- 2024-12-16
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.